MedTrace Logo

Prophylactic Early PN in HPT/BMT

NCT03083327 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 408

Last updated 2021-04-28

No results posted yet for this study

Summary

Supplemental prophylactic early parenteral nutrition will be commenced 1 day prior to conditioning chemoradiotherapy in patients who are not already malnourished. Supplemental parenteral nutrition continues throughout conditioning chemoradiotherapy and stem cell transplant.

Conditions

  • Hematologic Neoplasms

Interventions

DIETARY_SUPPLEMENT

Parenteral nutrition.

Nutrition support will be provides as per usual, but oral and enteral intake will be topped up with a standard parenteral nutrition solution. The standard parenteral nutrition solution will contain approximately 40 grams of amino acids/L, 40 g lipids/L and 100g dextrose/L).

OTHER

Pragmatic standard care.

Nutrition support will be provided as per usual care.

Sponsors & Collaborators

  • Australasian Bone Marrow Transplant Recipient Registry

    collaborator UNKNOWN

  • University of Roma La Sapienza

    collaborator OTHER

  • Northern Clinical School Intensive Care Research Unit, University of Sydney

    collaborator UNKNOWN

  • University of Sydney

    lead OTHER

Principal Investigators

  • Gordon S Doig, PhD · Northern Clinical School Intensive Care Research Unit, University of Sydney

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-23
Primary Completion
2021-12-01
Completion
2022-05-01

Countries

  • Australia
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03083327 on ClinicalTrials.gov